drugset / Trial / NCT00330499
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Phase 3
Completed
67 enrolled
Trans Tasman Radiation Oncology Group
National Health and Medical Research Council, Australia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to define the optimal management of localised transitional cell carcinoma (TCC) of the urinary bladder. The main objective is to evaluate whether chemoradiation is superior to radiotherapy alone.
Timeline
- Start
- 2002-10
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 35 mg/m2 | Intravenous |